white/neoplasms

CROSS-REFERENCE TO RELATED APPLICATION The application claims the benefit under 35 U.S.C. .sctn.119 of Korean Patent Application No. 10-2008-0136873, filed Dec. 30, 2008, which is hereby incorporated by reference in its entirety. FIELD OF THE INVENTION The present invention relates to a composition

BRIEF DESCRIPTION OF THE INVENTION The invention relates to treating neoplastic disease such as leukemia and increasing the white blood cell counts in patients suffering from neoplastic diseases or undergoing chemotherapy by a method which comprises administering parenterally to patients an

FIELD OF INVENTION This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure. BACKGROUND Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence

TECHNICAL FIELD6 The present invention relates to an endoscopic examination method and a lipid composition for improving diagnostic performance by applying a white opaque substance to diagnosis of gastric neoplasia. BACKGROUND TECHNOLOGY Gastric cancer is the disease with the second cause of cancer

BACKGROUND Circulating tumor cells (CTC) of epithelial origin are present in the blood of carcinoma patients at very low frequency (<10/ml blood). The detection of tumor cells in circulation may have significance for cancer disease management. The detection of low frequency cells requires a large

BACKGROUND Carcinomas are the most common form of cancer, and are responsible for the majority of cancer-related deaths worldwide. Early detection of cancer significantly improves a prognosis, as evidenced by the 70% reduction in mortality in cervical cancer that was observed after the Papanicolaou

FIELD OF THE INVENTION The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin. BACKGROUND OF THE

TECHNICAL FIELD This disclosure relates to methods for selecting antibodies having desirable characteristics from a population of diverse antibodies. More specifically, this disclosure provides methods for identifying antibodies which bind to cancer cells, but which do not bind to human red or white

BACKGROUND OF THE INVENTION A great number of pharmaceutically active ingredients are known in the art which inhibit the growth of tumor-cells, respectively kill tumor-cells or leukaemia cells. Usually, however, said active ingredients also inhibit to a certain extent the growth of the healthy

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to immunotherapy. More specifically the invention relates to the use of a patient-derived cell/non-patient cell hybrid as a therapeutic vaccine. Most specifically the invention relates to a novel cell line, FO-1 #12, for use

TECHNICAL FIELD One aspect of the present invention relates to a metal filter. Another aspect of the present invention relates to a method for concentrating cancer cells using a metal filter. The present invention also relates to a method for producing a metal filter, more specifically to a method

FIELD OF THE INVENTION This invention relates to the manufacture of novel chemical compounds which have biological activity, particularly to novel chemical compounds that are cytotoxic against colon cancer cells and colon cancer cell lines. BACKGROUND OF THE INVENTION Cancer is considered to be the

BACKGROUND OF THE INVENTION The present invention relates to devices and methods of use thereof for determining the presence and concentration of chemicals in a cell, tissue, organ or organism. The invention relates to, inter alia, semiderivative voltammetric measurements and chronoamperometric

BACKGROUND OF THE INVENTION Cancer is a significant cause of illness-related deaths in the United States. It is estimated that approximately 17,000 malignant brain tumors are diagnosed in adults and 1,500 in children every year in the United States. Brain tumors are usually lethal. Human brain

This is a National Phase Application filed under 35 U.S.C. 371 as a national stage of PCT/KR2010/005619, filed Aug. 24, 2010, and claiming the benefit from Korean Application No. 10-2009-0101003, filed Oct. 23, 2009, the content of each of which is hereby incorporated by reference in its